Physician

Amish J. Dave, M.D.

According to 2025 Medicare claims, Amish Dave, M.D. (NPI: 1013229772) practices rheumatology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is VIRGINIA MASON MEDICAL CENTER (NPI: 1730237942; TIN: 910565539) and primary practice location at 98110-5118. Dave is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Jefferson Accountable Care, LLC (ACO ID: A5275), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Dave's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 437 traditional Medicare patients, billed 1,786 HCPCS/CPT codes, and received $103,628 in Medicare payments. The top billing code was 90677 (Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use). Part D data shows 1,820 prescription claims across 376 beneficiaries totaling $2,816,126 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 12 records totaling $11,088. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,657 to $103,628. Similarly, Part D prescription costs have risen steadily, from $50,590 to $2,816,126. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	70	121	$8,657
2016	124	290	$20,710
2017	264	843	$56,183
2018	289	824	$55,533
2019	375	5,165	$102,523
2020	422	4,580	$108,922
2021	463	2,066	$133,496
2022	486	1,599	$108,306
2023	503	1,370	$115,939
2024	437	1,786	$103,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	159	$50,590
2016	69	220	$98,369
2017	156	681	$378,041
2018	186	874	$567,977
2019	295	1,543	$1,227,060
2020	355	2,125	$2,343,349
2021	334	2,051	$2,634,707
2022	339	1,884	$2,970,829
2023	374	1,811	$2,949,091
2024	376	1,820	$2,816,126

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90677	Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use	36	36	$290
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	118	118	$151
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	317	455	$127
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	262	347	$12
36415	Insertion of needle into vein for collection of blood sample	173	272	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	110	3,584	$868,562
Enbrel Sureclick	Etanercept	46	1,876	$479,392
Xeljanz Xr	Tofacitinib Citrate	34	1,080	$205,963
Cosentyx Sensoready (2 Pens)	Secukinumab	16	616	$158,631
Xeljanz	Tofacitinib Citrate	25	930	$150,315

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$11,088	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amish J. Dave, M.D.?

Tedicare shows public-source Medicare data for Amish J. Dave, M.D. (NPI 1013229772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amish J. Dave, M.D. have ACO affiliation data?

Amish J. Dave, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Jefferson Accountable Care, LLC (MSSP, ACO ID A5275), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Amish J. Dave, M.D.?

Amish J. Dave, M.D. is linked to VIRGINIA MASON MEDICAL CENTER (billing NPI 1730237942) in the available physician profile data.

Does Amish J. Dave, M.D. have Open Payments data?

Amish J. Dave, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.